With the aim of revitalizing the region, Tokushima Vortis was established with the support of local residents, government bodies, and companies. Otsuka Pharmaceutical and other Otsuka Group companies sponsor the team.

Full-scale entry into the Cosmedics^* business.

Antipsychotic drug

OPDC oversees the clinical development strategy and planning, as well as marketing planning, of Otsuka's pharmaceutical business in many Western countries.

Otsuka Pharmaceutical and UCB entered an agreement for co-development and co-promotion of pharmaceuticals in Japan including the anti-epileptic drug.

Busulfex is a conditioning agent for use prior to allogeneic hematopoietic progenitor cell transplantation.

A major mineral water company in Europe

Otsuka's second cosmedics brand (following the launch of InnerSignal three years earlier)

Oral vasopressin V₂-receptor antagonist

Leading company in the functional and nutritional food markets of Europe

Carbonated soy beverage

Opened as Otsuka Pharmaceutical's first in-house child care center in Tokushima

Heartful Kawauchi Co., Ltd. was established in Japan with the purpose to provide opportunities for people with physical and/or mental disabilities. It seeks to provide them with meaningful work in order to live equally with the rest of society and to work free from discrimination.

Otsuka entered into an agreement to develop new pharmaceuticals that use sensor technology.

Treatment for dry eye

Antipsychotic drug

Dopaminergic antiparkinsonian drug
Drug for restless legs syndrome